Skip to content
Sign in

EHC · NYSE

Encompass Health (EHC) Stock Price & Fundamentals

$669.86+0.41%+$2.71End-of-day price as of Oct 9, 2026

Encompass Health (EHC) closed at $669.86 on Oct 9, 2026, up 0.41% from the previous close of $667.15.

Share price, past year

1Y +17.31%

52-week range $544.74 – $677.61. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$669.86
Sep 30, 2026$669.25
Aug 31, 2026$647.35
Jul 31, 2026$654.69
Jun 30, 2026$639.03
May 29, 2026$617.62
Apr 30, 2026$620.90
Mar 31, 2026$625.70
Feb 27, 2026$604.23
Jan 30, 2026$566.05
Dec 31, 2025$566.89
Nov 28, 2025$557.55
Oct 31, 2025$579.92

Key statistics

Market cap
$66.08B
P/E (TTM)
109.1
EPS (TTM)
$6.14
Revenue (TTM)
$6.21B
Net income (TTM)
$621.00M
Shares outstanding
98.7M
Dividend yield
0.11%
52-week range
$544.74 – $677.61

Encompass Health's market cap is $66.08B, based on a share price of $669.86 and 98.7M shares outstanding as of Jul 28, 2026.

Financials

Encompass Health reported revenue of $5.94B for fiscal 2025, up 10.46% from fiscal 2024.

Encompass Health earned net income of $566.20M in fiscal 2025, a net margin of 9.5%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Encompass Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$5.94B+10.5%$566.20M9.5%$5.54—
FY2024ended Dec 31, 2024$5.37B+11.9%$455.70M8.5%$4.46—
FY2023ended Dec 31, 2023$4.80B+10.4%$352.00M7.3%$3.47—
FY2022ended Dec 31, 2022$4.35B+8.3%$271.00M6.2%$2.70$141.00M
FY2021ended Dec 31, 2021$4.01B+12.6%$412.20M10.3%$4.11$191.20M
FY2020ended Dec 31, 2020$3.57B−22.6%$284.20M8.0%$2.85$311.90M
FY2019ended Dec 31, 2019$4.61B+7.7%$358.70M7.8%$3.61$262.90M
FY2018ended Dec 31, 2018$4.28B+9.3%$292.30M6.8%$2.93$507.90M
FY2017ended Dec 31, 2017$3.91B+7.5%$271.10M6.9%$2.84$432.50M
FY2016ended Dec 31, 2016$3.64B—$247.60M6.8%$2.59$462.50M
Encompass Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$1.60B$153.90M$1.54
Q1 FY2026ended Mar 31, 2026$1.59B$194.50M$1.93
Q4 FY2025ended Dec 31, 2025$1.54B$146.10M$1.43
Q3 FY2025ended Sep 30, 2025$1.48B$126.50M$1.24
Q2 FY2025ended Jun 30, 2025$1.46B$142.10M$1.39
Q1 FY2025ended Mar 31, 2025$1.46B$151.50M$1.48
Q4 FY2024ended Dec 31, 2024$1.41B$120.90M$1.18
Q3 FY2024ended Sep 30, 2024$1.35B$108.20M$1.06

Company profile

Name
Encompass Health Corp
Ticker
EHC
Exchange
NYSE
Industry (SEC SIC)
Services-Hospitals
Headquarters
9001 Liberty Parkway, Birmingham, AL 35242
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0000785161

Recent SEC filings

Frequently asked questions

What is Encompass Health's stock price?

Encompass Health (EHC) closed at $669.86 on Oct 9, 2026, up 0.41% from the previous close of $667.15.

What is Encompass Health's market cap?

Encompass Health's market cap is $66.08B, based on a share price of $669.86 and 98.7M shares outstanding as of Jul 28, 2026.

How much revenue does Encompass Health make?

Encompass Health reported revenue of $5.94B for fiscal 2025, up 10.46% from fiscal 2024.

What is EHC's P/E ratio?

Encompass Health's price-to-earnings ratio is 109.1, based on trailing twelve-month diluted EPS of $6.14.

Does Encompass Health pay a dividend?

Yes. Encompass Health declared $0.76 per share in dividends over the last four quarters, a yield of 0.11%.

Sources and methodology

Fundamentals come from Encompass Health Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures